Indication
Colorectal adenocarcinoma
1 clinical trial
3 products
Clinical trial
A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07062119 IN PATIENTS WITH ADVANCED GASTROINTESTINAL TUMORSStatus: Terminated, Estimated PCD: 2023-11-28
Product
PF-07062119Product
Anti-PD1Product
Anti-VEGF